Adam L. Cohen

10.0k citations

138 papers · 3.6k indexed · 1 hit paper · h-index 34

Epidemiology top 1%
- Respiratory viral infections research 69
- Pneumonia and Respiratory Infections 64
- Influenza Virus Research Studies 58
- Pneumocystis jirovecii pneumonia detection and treatment 9
Microbiology top 1%
- Bacterial Infections and Vaccines 16
Modeling and Simulation top 1%
Health top 2%
- Vaccine Coverage and Hesitancy 22
Infectious Diseases top 2%
- Viral gastroenteritis research and epidemiology 13
Hepatology
- Hepatitis Viruses Studies and Epidemiology 9

Co-authors: Stefano Tempia Cheryl Cohen Sibongile Walaza Shabir A. Madhi Jocelyn Moyes Marietjie Venter Frederick P. Rivara Heather McPhillips
Cited by: Epidemiology Microbiology Modeling and Simulation
Partner nations: United States South Africa Switzerland

In The Last Decade

Adam L. Cohen

135 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2024 Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

Peers

Countries citing papers authored by Adam L. Cohen

Since Specialization

Citations

This map shows the geographic impact of Adam L. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam L. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam L. Cohen more than expected).

Fields of papers citing papers by Adam L. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam L. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam L. Cohen. The network helps show where Adam L. Cohen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Adam L. Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adam L. Cohen Line = papers co-authored together Adam L. Cohen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines Laura King,Kristin L. Andrejko,Miwako Kobayashi,Wei Xing,Adam L. Cohen,Wesley H. Self,J Jackson Resser,Cynthia G. Whitney,Adrienne Baughman,Mai Kio,Carlos G. Grijalva,Jessica Traenkner,Nadine Rouphael,Joseph A. Lewnard	2025	0
2	2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults Jeffrey A. Linder,Michael E. Watson,Michael R. Wessels,Danielle M Carter,Adam L. Cohen,Jennifer Dien Bard,Güliz Erdem,Christopher J. Gregory,Athena P. Kourtis,Judith M. Martin,A. Brian Mochon,Daniel J. Shapiro,Ryan W. Stevens,Dipleen Kaur,Miriam B. Barshak	2025	0
3	Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use — Two Cruise Ships, November 2022–July 2024 Sooji Lee,Chris Edens,Troy Ritter,Luis O. Rodriguez,Kara Tardivel,Natalia A. Kozak‐Muiznieks,Melisa J. Willby,Nancy Ortiz,Adam L. Cohen,Jessica C. Smith	2024	1
4	Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 – 2018 Jocelyn Moyes,Stefano Tempia,Sibongile Walaza,Adam L. Cohen,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Halima Dawood,Ebrahim Variava,Kathleen Kahn,Shabir A. Madhi,Cheryl Cohen	2024	1
5	Outpatient Visits and Antibiotic Use Due to Higher-Valency Pneumococcal Vaccine Serotypes Laura King,Kristin L. Andrejko,Sarah Kabbani,Sara Y. Tartof,Lauri A. Hicks,Adam L. Cohen,Miwako Kobayashi,Joseph A. Lewnard	2024	3
6	Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study Kristin L. Andrejko,Ryan Gierke,Jemma V. Rowlands,Jennifer B. Rosen,Ann Thomas,Zachary Landis,María Rosales,Sue Petit,William Schaffner,Corinne Holtzman,Meghan Barnes,Monica M. Farley,Lee H. Harrison,Lesley McGee,Sopio Chochua,Jennifer R. Verani,Adam L. Cohen,Tamara Pilishvili,Miwako Kobayashi	2024	15
7	The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016 Jocelyn Moyes,Stefano Tempia,Sibongile Walaza,Meredith McMorrow,Adam L. Cohen,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Halima Dawood,Ebrahim Variava,Kathleen Kahn,Shabir A. Madhi,Cheryl Cohen	2023	4
8	The national burden of influenza‐like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013–2015 Stefano Tempia,Jocelyn Moyes,Adam L. Cohen,Sibongile Walaza,Meredith McMorrow,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Halima Dawood,Ebrahim Variava,Cheryl Cohen	2022	13
9	Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009–2013 Oluwatosin Ayeni,Sibongile Walaza,Stefano Tempia,Michelle J. Groome,Kathleen Kahn,Shabir A. Madhi,Adam L. Cohen,Jocelyn Moyes,Marietjie Venter,Marthi Pretorius,Florette K. Treurnicht,Orienka Hellferscee,Anne von Gottberg,Nicole Wolter,Cheryl Cohen	2021	4
10	Influenza economic burden among potential target risk groups for immunization in South Africa, 2013–2015 Stefano Tempia,Jocelyn Moyes,Adam L. Cohen,Sibongile Walaza,Meredith McMorrow,Ijeoma Edoka,Heather Fraser,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Johanna M. McAnerney,Halima Dawood,Ebrahim Variava,Cheryl Cohen	2020	4
11	Influenza and tuberculosis co‐infection: A systematic review Sibongile Walaza,Cheryl Cohen,Stefano Tempia,Jocelyn Moyes,Athermon Nguweneza,Shabir A. Madhi,Meredith McMorrow,Adam L. Cohen	2019	37
12	The performance of different case definitions for severe influenza surveillance among HIV-infected and HIV-uninfected children aged <5 years in South Africa, 2011–2015 Hetani Ngobeni,Stefano Tempia,Adam L. Cohen,Sibongile Walaza,Lazarus Kuonza,Alfred Musekiwa,Anne von Gottberg,Orienka Hellferscee,Nicole Wolter,Florette K. Treurnicht,Jocelyn Moyes,Fathima Naby,Omphile Mekgoe,Cheryl Cohen	2019	2
13	Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015 Stefano Tempia,Jocelyn Moyes,Adam L. Cohen,Sibongile Walaza,Ijeoma Edoka,Meredith McMorrow,Florette K. Treurnicht,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Athermon Nguweneza,Johanna M. McAnerney,Halima Dawood,Ebrahim Variava,Cheryl Cohen	2019	28
14	Replacement of neuraminidase inhibitor‐susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009‐2013, South Africa Florette K. Treurnicht,Amelia Buys,Stefano Tempia,Mpho Seleka,Adam L. Cohen,Sibongile Walaza,Allison Glass,Inèz Rossouw,Johanna M. McAnerney,Lucille Blumberg,Cheryl Cohen,Marietjie Venter	2018	7
15	The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza‐associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013‐2015 Stefano Tempia,Sibongile Walaza,Jocelyn Moyes,Adam L. Cohen,Claire von Mollendorf,Meredith McMorrow,Sarona Mhlanga,Florette K. Treurnicht,Marietjie Venter,Marthi Pretorius,Orienka Hellferscee,Nicole Wolter,Anne von Gottberg,Arthemon Nguweneza,Johanna M. McAnerney,Halima Dawood,Ebrahim Variava,Shabir A. Madhi,Cheryl Cohen	2017	17
16	Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals Jazmin Duque,Sisanda Gaga,David A. Clark,Madeleine Muller,Bulenani Kuwane,Cheryl Cohen,Sibongile Walaza,Stefano Tempia,Puleng Ramatoboe,Tsakani Furumele,Marc‐Alain Widdowson,Meredith McMorrow,Adam L. Cohen	2017	11
17	Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting Jocelyn Moyes,Sibongile Walaza,Marthi Pretorius,Michelle J. Groome,Anne von Gottberg,Nicole Wolter,Sumayya Haffejee,Ebrahim Variava,Adam L. Cohen,Stefano Tempia,Kathleen Kahn,Halima Dawood,Marietjie Venter,Cheryl Cohen,Shabir A. Madhi	2017	28
18	The national burden of influenza‐associated severe acute respiratory illness hospitalization in Zambia, 2011‐2014 Andros Theo,Stefano Tempia,Adam L. Cohen,Paul Simusika,Edward Chentulo,Chikama Mukwangole Chikamukwa,Mwaka Monze	2017	25
19	Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa Stefano Tempia,Nicole Wolter,Cheryl Cohen,Sibongile Walaza,Claire von Mollendorf,Adam L. Cohen,Jocelyn Moyes,Linda de Gouveia,Susan Nzenze,Florette K. Treurnicht,Marietjie Venter,Michelle J. Groome,Shabir A. Madhi,Anne von Gottberg	2015	15
20	Economic Analysis of Prevaccination Serotesting Compared With Presumptive Immunization for Polio, Diphtheria, and Tetanus in Internationally Adopted and Immigrant Infants Adam L. Cohen,David L. Veenstra	2006	12

About Adam L. Cohen

Adam L. Cohen is a scholar working on Epidemiology, Health and Microbiology, having authored 138 papers that have together received 3.6k indexed citations. Recurring topics across this work include Respiratory viral infections research (69 papers), Pneumonia and Respiratory Infections (64 papers), Influenza Virus Research Studies (58 papers), Vaccine Coverage and Hesitancy (22 papers), Bacterial Infections and Vaccines (16 papers), Viral gastroenteritis research and epidemiology (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Hepatitis Viruses Studies and Epidemiology (9 papers). The work is most often cited by research in Epidemiology (2.2k citations), Microbiology (356 citations) and Modeling and Simulation (216 citations). Adam L. Cohen has collaborated with scholars based in United States, South Africa and Switzerland. Frequent co-authors include Stefano Tempia, Cheryl Cohen, Sibongile Walaza, Shabir A. Madhi, Jocelyn Moyes, Marietjie Venter, Frederick P. Rivara, Heather McPhillips, Robert Davis and Edgar K. Marcuse.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact